UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

Nature communications, 2018-11, Vol.9 (1), p.4664-5, Article 4664

2018

Volltextzugriff (PDF)

Pulmonary toxicity in patients treated with immune checkpoint inhibitors and radiation

Annals of oncology, 2020-12, Vol.31 (12), p.1597-1598

2020

Volltextzugriff (PDF)

Surprising impact of stromal TIL’s on immunotherapy efficacy in a real-world lung cancer study

Lung cancer (Amsterdam, Netherlands), 2021-03, Vol.153, p.81-89

2021

Volltextzugriff (PDF)

Detection of colorectal cancer in urine using DNA methylation analysis

Scientific reports, 2021-01, Vol.11 (1), p.2363-11, Article 2363

2021

Volltextzugriff (PDF)

A protocol for urine collection and storage prior to DNA methylation analysis

PloS one, 2018-08, Vol.13 (8), p.e0200906-e0200906

2018

Volltextzugriff (PDF)

Population-based survival rates after curative surgical and non-surgical treatment of stage III NSCLC since 2017

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107532, Article 107532

2024

Volltextzugriff (PDF)

Diagnosis and management of pneumonitis following chemoradiotherapy and immunotherapy in stage III non-small cell lung cancer

Radiotherapy and oncology, 2024-05, Vol.194, p.110147, Article 110147

2024

Volltextzugriff (PDF)

The effect of tumor size and metastatic extent on the efficacy of first line pembrolizumab monotherapy in patients with high PD-L1 expressing advanced NSCLC tumors

Lung cancer (Amsterdam, Netherlands), 2021-12, Vol.162, p.36-41

2021

Volltextzugriff (PDF)

Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET

Lung cancer (Amsterdam, Netherlands), 2017-05, Vol.107, p.1-13

2017

Volltextzugriff (PDF)

Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2023-08, Vol.182, p.107294-107294, Article 107294

2023

Volltextzugriff (PDF)

Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients

Pharmaceuticals (Basel, Switzerland), 2022-06, Vol.15 (7), p.796

2022

Volltextzugriff (PDF)

Detection of non-metastatic non-small-cell lung cancer in urine by methylation-specific PCR analysis: A feasibility study

Lung cancer (Amsterdam, Netherlands), 2022-08, Vol.170, p.156-164

2022

Volltextzugriff (PDF)

P06.02 Incorporating Surgical Collapse in the Pathological Assessment of Resected Adenocarcinoma in situ of the Lung. A Proof of Principle Study

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S985-S985

2021

Volltextzugriff (PDF)

A nationwide population-based cohort study of surgical care for patients with superior sulcus tumors: Results from the Dutch Lung Cancer Audit for Surgery (DLCA-S)

Lung cancer (Amsterdam, Netherlands), 2021-11, Vol.161, p.42-48

2021

Volltextzugriff (PDF)

Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry

Lung cancer (Amsterdam, Netherlands), 2020-02, Vol.140, p.107-112

2020

Volltextzugriff (PDF)

Quantification of [18F]afatinib using PET/CT in NSCLC patients: a feasibility study

EJNMMI research, 2020-08, Vol.10 (1), p.97-97, Article 97

2020

Volltextzugriff (PDF)

Long-Term Outcomes After Chemoradiotherapy and Surgery for Superior Sulcus Tumors

JTO clinical and research reports, 2023-04, Vol.4 (4), p.100475-100475, Article 100475

2023

Volltextzugriff (PDF)

Evaluation of a care path for patients with lung tumors and co-existing interstitial lung disease

Annals of oncology, 2019-04, Vol.30, p.ii21-ii21

2019

Volltextzugriff (PDF)

ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib

Lung cancer (Amsterdam, Netherlands), 2019-12, Vol.138, p.13-18

2019

Volltextzugriff (PDF)

A randomized phase II study comparing paclitaxel–carboplatin–bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)

Annals of oncology, 2015-11, Vol.26 (11), p.2286-2293

2015

Volltextzugriff (PDF)

Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC

Lung cancer (Amsterdam, Netherlands), 2014-08, Vol.85 (2), p.205-212

2014

Volltextzugriff (PDF)

CT-perfusion versus [15O]H2O PET in lung tumors: Effects of CT-perfusion methodology

Medical physics (Lancaster), 2013-05, Vol.40 (5), p.052502-n/a

2013

Volltextzugriff (PDF)

1304P A structured multidisciplinary approach for diagnosing immune-related pneumonitis in patients undergoing adjuvant durvalumab for stage III non-small cell lung cancer

Annals of oncology, 2023-10, Vol.34, p.S751-S751

2023

Volltextzugriff (PDF)

Neoadjuvant immune checkpoint inhibitors in resectable non-small-cell lung cancer: a systematic review

ESMO open, 2021-10, Vol.6 (5), p.100244, Article 100244

2021

Volltextzugriff (PDF)

Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumors

Strahlentherapie und Onkologie, 2014-02, Vol.190 (2), p.204-209

2014

Volltextzugriff (PDF)

1 – 25 von 375

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(318)
Mit Volltextzugriff
(305)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

Pulmonary toxicity in patients treated with immune checkpoint inhibitors and radiation

Surprising impact of stromal TIL’s on immunotherapy efficacy in a real-world lung cancer study

Detection of colorectal cancer in urine using DNA methylation analysis

A protocol for urine collection and storage prior to DNA methylation analysis

Population-based survival rates after curative surgical and non-surgical treatment of stage III NSCLC since 2017

Diagnosis and management of pneumonitis following chemoradiotherapy and immunotherapy in stage III non-small cell lung cancer

The effect of tumor size and metastatic extent on the efficacy of first line pembrolizumab monotherapy in patients with high PD-L1 expressing advanced NSCLC tumors

Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET

Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer

Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients

Detection of non-metastatic non-small-cell lung cancer in urine by methylation-specific PCR analysis: A feasibility study

P06.02 Incorporating Surgical Collapse in the Pathological Assessment of Resected Adenocarcinoma in situ of the Lung. A Proof of Principle Study

A nationwide population-based cohort study of surgical care for patients with superior sulcus tumors: Results from the Dutch Lung Cancer Audit for Surgery (DLCA-S)

Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry

Quantification of [18F]afatinib using PET/CT in NSCLC patients: a feasibility study

Long-Term Outcomes After Chemoradiotherapy and Surgery for Superior Sulcus Tumors

Evaluation of a care path for patients with lung tumors and co-existing interstitial lung disease

ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib

A randomized phase II study comparing paclitaxel–carboplatin–bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)

Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC

CT-perfusion versus [15O]H2O PET in lung tumors: Effects of CT-perfusion methodology

1304P A structured multidisciplinary approach for diagnosing immune-related pneumonitis in patients undergoing adjuvant durvalumab for stage III non-small cell lung cancer

Neoadjuvant immune checkpoint inhibitors in resectable non-small-cell lung cancer: a systematic review

Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumors

Suchergebnisse filtern